NBR1 is a critical step in the repression of thermogenesis of p62-deficient adipocytes through PPARγ

Activation of non-shivering thermogenesis is considered a promising approach to lower body weight in obesity. p62 deficiency in adipocytes reduces systemic energy expenditure but its role in sustaining mitochondrial function and thermogenesis remains unresolved. NBR1 shares a remarkable structural similarity with p62 and can interact with p62 through their respective PB1 domains. However, the physiological relevance of NBR1 in metabolism, as compared to that of p62, was not clear. Here we show that whole-body and adipocyte-specific ablation of NBR1 reverts the obesity phenotype induced by p62 deficiency by restoring global energy expenditure and thermogenesis in brown adipose tissue. Impaired adrenergic-induced browning of p62-deficient adipocytes is rescued by NBR1 inactivation, unveiling a negative role of NBR1 in thermogenesis under conditions of p62 loss. We demonstrate that upon p62 inactivation, NBR1 represses the activity of PPARγ, establishing an unexplored p62/NBR1-mediated paradigm in adipocyte thermogenesis that is critical for the control of obesity.


Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals) For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable.

For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.

Software and code
Policy information about availability of computer code Data collection

Data analysis
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.

Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: -Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability We did not perform statistical calculations of sample-size. Sample size was determined based on reproducibility between biological replicates and independent experiments as well as the magnitude and consistency of measurable differences between groups. For animal experiments, cohort size was determined by types of experiment and availability of animals as littermates were used in each experiment.
We have not excluded any data.
Animal experiments were independently performed for at least two times with similar findings. In vitro data have been performed independently for at least three times with similar results. Despite technical problems (eg: poor protein or RNA quality after cell/tissue lysis, low primary cell viability after isolation, poor cell differentiation rate, poor DNA transfection efficiency or pipetting errors) all replicates show similar results.
Subject animals using global knockout mice were randomly assigned in animal experiments but the animals from the tissue-specific knockout lines were not randomly assigned because flox and cre genotyping of each subject to discriminate the wild-type and knockout is required prior to the animal experiments. Sex-and age-matched animals were allocated from each genotype into experimental groups. For in vitro cell based experiments, individual wells were randomized into treatment groups and were processed at the same time to control for potential covariates.
For animal experiment, investigators were not blinded to genotypes and treatment conditions because information on sex, age and genotypes is prerequisite for the group assignment.